Browse by all authors Browse By Author Name - Ulrich,+R

Browse Results (5 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Ulrich, R, Koletzki, D, Zankl, A, Schulz, A, Meisel, H, Kruger, DH, Gelderblom, HR, Dislers, A, Borisova, G and Pumpens, P (1997). A new strategy to generate mosaic HBcAg particles presenting foreign epitopes. In: Vaccines 97 - Molecular Approaches to the Control of Infectious Diseases. 14th Annual Meeting on Modern Approaches to the Control of Infectious Diseases, Cold Spring Harbor Ny, (235-240). Sep 09-13, 1996. 36   3
Norton, A. A., Ulrich, R. K., Bush, R. I. and Tarbell, T. D. (1999) Characteristics of magnetohydrodynamic oscillations observed with the Michelson doppler imager. The Astrophysical Journal, 518 L123-L126. 25  
Bacon, J. A., Ulrich, R. G., Davis, J. P., Thomas, E. M., Johnson, S. S., Conder, G. A., Sangster, N. C., Rothwell, J. T., McCracken, R. O., Lee, B. H., Clothier, M. F., Geary, T. G. and Thompson, D. P. (1998) Comparative in vitro effects of closantel and selected beta-ketoamide anthelmintics on a gastrointestinal nematode and vertebrate liver cells. Journal of Veterinary Pharmacology And Therapeutics, 21 3: 190-198. doi:10.1046/j.1365-2885.1998.00139.x 56   10 Cited 9 times in Scopus9 0
Koletzki, D, Zankl, A, Gelderblom, HR, Meisel, H, Dislers, A, Borisova, G, Pumpens, P, Kruger, DH and Ulrich, R (1997) Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. Journal of General Virology, 78 2049-2053. 14   18
Ulrich, R, Koletzki, D, Lachmann, S, Lundkvist, A, Zankl, A, Kazaks, A, Kurth, A, Gelderblom, HR, Borisova, G, Meisel, H and Kruger, DH (1999). New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. In: Journal of Biotechnology. Conference on New Approaches in Vaccine Development 1997 (NAVD 97), Vienna Austria, (141-153). 1997. doi:10.1016/S0168-1656(99)00117-0 20   25 Cited 29 times in Scopus29 0